| Literature DB >> 18704413 |
Katrin Kösters1, Reinout van Crevel, Patrick D J Sturm, B Willem Schreurs, Maarten C de Waal Malefijt, Albert van Kampen, Bart Jan Kullberg.
Abstract
Our objective was to evaluate different treatment alternatives for total knee arthroplasty (TKA) infection and to compare outcomes depending on adherence to a current treatment algorithm. All patients treated for a first episode of TKA infection between January 2000 and July 2005 were included. Patient records were reviewed and data were extracted retrospectively. Fifteen patients were followed up for a median of 25 months. The cure rate in patients with two-stage exchange of knee prosthesis was higher than in patients who had débridement without implant removal (100 vs 37%, p = 0.03). Cure rates were not different between these two surgical approaches in ten patients who were treated according to a current treatment algorithm. Success rates for treatment of TKA infections varied considerably with the treatment strategy chosen. Our results support the use of existing algorithms to select patients who are eligible for débridement with retention of the prosthesis or need two-stage exchange of knee implants.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18704413 PMCID: PMC2899127 DOI: 10.1007/s00264-008-0638-4
Source DB: PubMed Journal: Int Orthop ISSN: 0341-2695 Impact factor: 3.075
Fig. 1Algorithm for treatment of prosthetic joint infections [13, 14]
Summary of patient characteristics, infection parameters, treatment delay, microorganisms, surgical intervention and outcome
| Patient | Age | Gender | Type of infection | CRP (mg/l) | ESR (mm/h) | WBC (/nl) | Immunosuppression | Antibiotic therapy | Procedure chosen according to published treatment algorithm [ | Treatment delay (days) | Microorganism | Surgical intervention | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 84 | F | Early | 14 | 126 | 3.2 | Prednisone | Ciprofloxacin | Yes | 1 |
| Débridement | Success |
| 2 | 64 | M | Late acute | Clindamycin | Yes | 1 | Negative | Débridement | Success | ||||
| 3 | 46 | M | Late acute | 319 | 72 | 18.8 | Amoxicillin | Yes | 3 | BHS gr B | Débridement | Failure | |
| 4 | 73 | M | Late acute | Prednisone | Clindamycin/rifampicin | Yes | 21 | BHS gr G | Débridement | Success | |||
| 5 | 81 | F | Late chronic | Clindamycin/rifampicin | No | 546 | CNS | Débridement | Failure | ||||
| 6 | 58 | F | Late acute | 80 | 59 | 6.8 | Anti-TNF alpha | Clindamycin | No | 60 |
| Débridement | Failure |
| 7 | 32 | M | Delayed | 24 | 20 | 5.9 | Azathioprine | Ciprofloxacin/rifampicin | No | 90 | CNS | Débridement | Failure |
| 8 | 76 | M | Early | 42 | 55 | 8.3 | Ciprofloxacin/rifampicin | No | 28 |
| Débridement | Failure | |
| 9 | 66 | F | Early | ≤ 5 | 11 | 6.4 | Clindamycin/ciprofloxacin | Yes | 365 | CNS | Two-stage exchange | Success | |
| 10 | 70 | M | Early | 5 | 9 | 4.1 | Clindamycin | Yes | 301 | Negative | Two-stage exchange | Success | |
| 11 | 74 | M | Late chronic | 5 | 2 | Clindamycin | Yes | 910 | CNS, | Two-stage exchange | Success | ||
| 12 | 25 | F | Delayed | 5 | 5.6 | Azathioprine | Clindamycin | Yes | 819 |
| Two-stage exchange | Success | |
| 13 | 61 | F | Delayed | 12 | 35 | 7.9 | Clindamycin | Yes | 1820 | CNS | Two-stage exchange | Success | |
| 14 | 51 | F | Late chronic | 115 | 56 | 5.6 | Clindamycin | Yes | 91 | CNS | Two-stage exchange | Success | |
| 15 | 42 | M | Early | Ciprofloxacin/teicoplanin | Yes | 301 | CNS, | Arthrodesis | Failure |
CRP C-reactive protein, ESR erythrocyte sedimentation rate, WBC white blood cell count, BHS gr B beta-haemolytic streptococcus group B, BHS gr G beta-haemolytic streptococcus group G, CNS coagulase-negative Staphylococcus
Success rate according to underlying disease, immunosuppression, mono- or polymicrobial infection, classification of TKA infection, type of antibiotic therapy and adherence to a published treatment algorithm [13, 14]
| Success rate ( | ||
|---|---|---|
| Microorganism | Monomicrobial | 6/11 |
| Polymicrobial | 1/2 | |
| Classification | Early | 3/5 |
| Delayed | 2/3 | |
| Late | 4/7 | |
| Antibiotic therapy | Combination including rifampicin | 2/4 |
| Clindamycin monotherapy | 6/8 | |
| Other | 1/3 | |
| Immunosuppression | Yes | 3/5 |
| No | 6/10 | |
| Underlying disease | Degenerative joint disease | 5/9 |
| Rheumatoid arthritis | 4/6 | |
| Treatment | According to protocol | 9/11 |
| Not according to protocol | 0/4 |